irblog.prnewswire.com

Cardea secures international patent coverage for its pioneering work on developing mass-produced graphene biosensors

SAN DIEGO, April 27, 2022 /PRNewswire/ -- Today, Cardea Bio, Inc. - the world's first mass producer of graphene biosensors - shares their continued success to secure broad intellectual property (IP) ...
Business Wire

Cardea Bio Adds $6.5 Million to Series A; Early-Stage Financing Now Totals More Than $20 Million

SAN DIEGO--(BUSINESS WIRE)--Cardea Bio, Inc., a Tech+Bio company integrating molecular biology with semiconductors via Graphene-based biology-gated Transistors, announced today a $6.5M series A ...
Business Wire

Cardiac Insight Reports Increased Cardea 20/20 ECG™ Sales to Screen Young Athletes for Conditions at Risk for Sudden Cardiac Arrest

BELLEVUE, Wash.--(BUSINESS WIRE)--Cardiac Insight, Inc., a healthcare innovator specializing in wearable electrocardiogram (ECG) cardiac sensors and proven automated ECG analysis that delivers ...
irblog.prnewswire.com

Cardea Bio completes planned launch of CRISPR QC

SAN DIEGO, April 5, 2022 /PRNewswire/ -- Today, Cardea Bio, Inc. - the world's only mass producer of biocompatible semiconductors - announced a significant milestone with the launch of CRISPR QC Inc.
Yahoo Finance

Global Blockchain Acquisition Corp. and Cardea Corporate Holdings, Inc. Announce the Execution of a Definitive Merger Agreement

ORLANDO, FL and ATLANTA, GA, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Global Blockchain Acquisition Corp. (NASDAQ: GBBK) ("GBBK"), a publicly traded special purpose acquisition company, and Cardea Corporate ...